Metraipolis › archive › dc_1ace8a29547d

Repurposing of semaglutide by targeting SIRT1 and TGF-β/Smad signaling in hepatic fibrosis — Europe PMC PMID:41111129

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41111129
DOI
10.1007/s00210-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-09T04:56:54.325Z
SHA-256 of the archived text
ed50a21671d074ab07b335a5f615b6155c07c4a8ffefce5729fd432ba9c1e4be
Stable URL of this page
https://metraipolis.com/documento/dc_1ace8a29547d

How to cite

Repurposing of semaglutide by targeting SIRT1 and TGF-β/Smad signaling in hepatic fibrosis — Europe PMC PMID:41111129 — Europe PMC (en), https://europepmc.org/article/MED/41111129 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1ace8a29547d (Metraipolis archive dc_1ace8a29547d, sha256 ed50a21671d074ab07b335a5f615b6155c07c4a8ffefce5729fd432ba9c1e4be)
BibTeX
@misc{dc1ace8a29547d,
  title = {Repurposing of semaglutide by targeting SIRT1 and TGF-β/Smad signaling in hepatic fibrosis — Europe PMC PMID:41111129},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41111129},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1ace8a29547d; sha256 ed50a21671d074ab07b335a5f615b6155c07c4a8ffefce5729fd432ba9c1e4be},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41111129. Agents can read the archived copy with the MCP tool read_document.